Table 3 Correlation between clinicopathological characteristics and operative time
Characteristics | N (%) | Operative time | p-value |
|---|---|---|---|
Age, years | 0.955 | ||
<65 | 12 (24) | 280.9 ± 109.8 | |
≥65 | 38 (76) | 283.2 ± 125.0 | |
Gender | 0.301 | ||
Female | 19 (38) | 259.9 ± 117.3 | |
Male | 31 (62) | 296.6 ± 122.2 | |
Symptoms | 0.002 | ||
No | 17 (34) | 210.2 ± 90.3 | |
Yes | 33 (66) | 319.9 ± 118.0 | |
BMI | 0.059 | ||
Overweight or obesity | 28 (56) | 311.1 ± 121.8 | |
Normal weight | 22 (44) | 246.4 ± 111.1 | |
Smoking | 0.011 | ||
Yes | 18 (36) | 339.6 ± 125.8 | |
No | 32 (64) | 250.6 ± 106.4 | |
Hemoglobin, g/L | 0.119 | ||
<118 | 24 (48) | 310.8 ± 138.6 | |
≥118 | 26 (52) | 256.6 ± 96.5 | |
Tumor size, cm | 0.001 | ||
<6.3 | 25 (50) | 228.3 ± 99.8 | |
≥6.3 | 25 (50) | 337.0 ± 116.4 | |
Risk classification | 0.001 | ||
High | 37 (74) | 314.1 ± 116.1 | |
Very low or low | 13 (26) | 193.0 ± 84.2 | |
Location | 0.709 | ||
Duodenum | 45 (90) | 280.5 ± 117.8 | |
Proximal jejunum | 5 (10) | 302.0 ± 156.7 | |
Liver metastases | 0.224 | ||
Yes | 12 (24) | 327.7 ± 149.8 | |
No | 38 (76) | 268.4 ± 108.1 | |
Neoadjuvant therapy | 0.297 | ||
Yes | 18 (36) | 306.6 ± 122.4 | |
No | 32 (64) | 269.2 ± 119.2 | |
ASA | 0.758 | ||
III | 5 (10) | 298.6 ± 159.4 | |
I or II | 45 (90) | 280.9 ± 117.6 | |
Bypass | 0.033 | ||
With | 23 (46) | 321.7 ± 107.1 | |
Without | 27 (54) | 249.3 ± 123.1 | |
Multi-visceral resection | < 0.001 | ||
Yes | 18 (36) | 381.0 ± 108.8 | |
No | 32 (64) | 227.3 ± 87.6 |